BACKGROUND & AIMS: NK1.1(+) TCRalphabeta(int) CD1-restricted T (NKT) cells are a unique subset of T lymphocytes that are believed to have an immunoregulatory role in a wide range of diseases. Most mouse NKT cells express a T-cell receptor that contains an invariant Valpha14Jalpha18 chain and recognizes antigenic glycolipids presented in association with major histocompatibility complex class Ib (CD1d) molecules. These invariant NKT (iNKT) cells have been implicated in cholestatic liver injury. METHODS: We examined the role of iNKT cells in liver injury associated with biliary obstruction in mice with ligations of the common bile duct. RESULTS: The number of activated iNKT cells increased markedly in the livers of mice following bile duct ligation. Plasma alanine aminotransferase levels, an indicator of liver injury, were significantly higher in iNKT cell-deficient (Jalpha18(-/-)) mice compared with wild-type mice following bile duct ligation. Photo image analysis of histologic sections confirmed that more damage was present in the livers of Jalpha18(-/-) mice; liver damage correlated with increases in keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) production as well as neutrophil sequestration. Liver injury was significantly reduced in Jalpha18(-/-) mice treated with anti-KC and anti-MIP-2 or rendered neutrophil deficient before bile duct ligation. Similarly, Jalpha18(-/-) mice that were injected with iNKT cells before bile duct ligation exhibited significant decreases in neutrophil accumulation and liver damage. CONCLUSIONS: These data document the role of iNKT cells in suppressing the neutrophil proinflammatory response and neutrophil-dependent cholestatic liver damage.
BACKGROUND & AIMS:NK1.1(+) TCRalphabeta(int) CD1-restricted T (NKT) cells are a unique subset of T lymphocytes that are believed to have an immunoregulatory role in a wide range of diseases. Most mouse NKT cells express a T-cell receptor that contains an invariant Valpha14Jalpha18 chain and recognizes antigenic glycolipids presented in association with major histocompatibility complex class Ib (CD1d) molecules. These invariant NKT (iNKT) cells have been implicated in cholestatic liver injury. METHODS: We examined the role of iNKT cells in liver injury associated with biliary obstruction in mice with ligations of the common bile duct. RESULTS: The number of activated iNKT cells increased markedly in the livers of mice following bile duct ligation. Plasma alanine aminotransferase levels, an indicator of liver injury, were significantly higher in iNKT cell-deficient (Jalpha18(-/-)) mice compared with wild-type mice following bile duct ligation. Photo image analysis of histologic sections confirmed that more damage was present in the livers of Jalpha18(-/-) mice; liver damage correlated with increases in keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) production as well as neutrophil sequestration. Liver injury was significantly reduced in Jalpha18(-/-) mice treated with anti-KC and anti-MIP-2 or rendered neutrophil deficient before bile duct ligation. Similarly, Jalpha18(-/-) mice that were injected with iNKT cells before bile duct ligation exhibited significant decreases in neutrophil accumulation and liver damage. CONCLUSIONS: These data document the role of iNKT cells in suppressing the neutrophil proinflammatory response and neutrophil-dependent cholestatic liver damage.
Authors: Stephen H Gregory; Leslie P Cousens; Nico van Rooijen; Ed A Döpp; Timothy M Carlos; Edward J Wing Journal: J Immunol Date: 2002-01-01 Impact factor: 5.422
Authors: K J Hammond; D G Pellicci; L D Poulton; O V Naidenko; A A Scalzo; A G Baxter; D I Godfrey Journal: J Immunol Date: 2001-08-01 Impact factor: 5.422
Authors: Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina Journal: J Leukoc Biol Date: 2007-09-20 Impact factor: 4.962
Authors: Y Kaneko; M Harada; T Kawano; M Yamashita; Y Shibata; F Gejyo; T Nakayama; M Taniguchi Journal: J Exp Med Date: 2000-01-03 Impact factor: 14.307
Authors: Daniel B Stetson; Markus Mohrs; R Lee Reinhardt; Jody L Baron; Zhi-En Wang; Laurent Gapin; Mitchell Kronenberg; Richard M Locksley Journal: J Exp Med Date: 2003-10-06 Impact factor: 14.307
Authors: Patrick Benoit; Vaia Yioula Sigounas; Jenna L Thompson; Nico van Rooijen; Matthew E Poynter; Matthew J Wargo; Jonathan E Boyson Journal: Infect Immun Date: 2015-04-13 Impact factor: 3.441
Authors: Sébastien Jaillon; Maria Rosaria Galdiero; Davide Del Prete; Marco Antonio Cassatella; Cecilia Garlanda; Alberto Mantovani Journal: Semin Immunopathol Date: 2013-04-04 Impact factor: 9.623
Authors: Daithi S Heffernan; Sean F Monaghan; Rajan K Thakkar; Mai L Tran; Chun-Shiang Chung; Stephen H Gregory; William G Cioffi; Alfred Ayala Journal: Shock Date: 2013-08 Impact factor: 3.454
Authors: Gerhard Wingender; Marcus Hiss; Isaac Engel; Konrad Peukert; Klaus Ley; Hermann Haller; Mitchell Kronenberg; Sibylle von Vietinghoff Journal: J Immunol Date: 2012-03-02 Impact factor: 5.422
Authors: Kate M O'Brien; Katryn M Allen; Cheryl E Rockwell; Keara Towery; James P Luyendyk; Bryan L Copple Journal: Am J Pathol Date: 2013-09-05 Impact factor: 4.307
Authors: Caroline C Duwaerts; Stephan Gehring; Chao-Wen Cheng; Nico van Rooijen; Stephen H Gregory Journal: Liver Int Date: 2012-12-13 Impact factor: 5.828